Testing effectiveness (Phase 2)Study completedNCT04025554
What this trial is testing
Anakinra for the Treatment of Chronically Inflamed White Matter Lesions in Multiple Sclerosis
Who this might be right for
Multiple Sclerosis
National Institute of Neurological Disorders and Stroke (NINDS) 8